AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 66 filers reported holding AVROBIO INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,402,000 | +7.1% | 244,032 | 0.0% | 0.08% | -33.6% |
| Q3 2020 | $3,177,000 | -42.7% | 244,032 | -23.2% | 0.12% | -42.2% |
| Q2 2020 | $5,542,000 | +12.1% | 317,579 | 0.0% | 0.21% | -8.3% |
| Q1 2020 | $4,942,000 | -22.7% | 317,579 | 0.0% | 0.23% | -9.8% |
| Q4 2019 | $6,393,000 | -20.3% | 317,579 | -44.1% | 0.26% | -47.7% |
| Q3 2019 | $8,024,000 | +79.4% | 568,294 | +106.7% | 0.49% | +89.9% |
| Q2 2019 | $4,472,000 | -32.4% | 275,000 | -8.3% | 0.26% | -42.5% |
| Q1 2019 | $6,615,000 | -70.7% | 300,000 | -77.9% | 0.45% | -75.6% |
| Q4 2018 | $22,607,000 | -70.8% | 1,357,784 | -9.0% | 1.84% | -63.5% |
| Q3 2018 | $77,431,000 | +79.8% | 1,492,784 | -1.0% | 5.03% | +57.9% |
| Q2 2018 | $43,062,000 | – | 1,507,783 | – | 3.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,417,204 | $28,528,000 | 17.28% |
| Aisling Capital Management LP | 893,079 | $17,978,000 | 6.89% |
| AlpInvest Partners B.V. | 200,732 | $4,041,000 | 3.44% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $20,130,000 | 2.40% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $6,352,000 | 1.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,164,970 | $23,451,000 | 0.75% |
| Eventide Asset Management | 1,305,307 | $26,276,000 | 0.74% |
| Camber Capital Management LP | 600,000 | $12,078,000 | 0.62% |
| EMERALD ADVISERS, LLC | 656,306 | $13,211,000 | 0.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 641,387 | $12,911,000 | 0.53% |